How is the Cabaletta Bio Inc today?

The Cabaletta Bio Inc today is trading in the down by -10.16% at 1.15.

What is Cabaletta Bio Inc Annual Net Profit?

Cabaletta Bio Inc Annual Net Profit fell 71.21% in the last year to $115.86 M. Its sector's average net profit growth for the last fiscal year was -32.49%.

What is Cabaletta Bio Inc Price to Earning Ratio?

Cabaletta Bio Inc Price to Earning Ratio is -0.5, which is negative.

What is Cabaletta Bio Inc Stock Price?

Cabaletta Bio Inc Stock Price fell 90.72% and underperformed its sector by 95.23% in the past year.

What is Cabaletta Bio Inc Quarterly Net profit?

Cabaletta Bio Inc Quarterly Net profit fell 56.02% YoY to $32.59 M. Its sector's average net profit growth YoY for the quarter was -29.04%.

What is Cabaletta Bio Inc Debt to Equity Ratio?

Cabaletta Bio Inc Debt to Equity Ratio of 0.1 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Cabaletta Bio Inc Return on Equity(ROE)?

Cabaletta Bio Inc Return on Equity(ROE) for the last financial year was -59.64%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Cabaletta Bio Inc Mutual Fund Holding?

Cabaletta Bio Inc Mutual Fund Holding decreased by 5.31% in the last quarter to 42.74.

What is Cabaletta Bio Inc Promoter Share Holding?

Cabaletta Bio Inc Promoter Share Holding stayed the same in the most recent quarter at 4.4%.

What is Cabaletta Bio Inc Interest Coverage Ratio?

Cabaletta Bio Inc Interest Coverage Ratio is -153.9, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Cabaletta Bio Inc XNAS: CABA

Cabaletta Bio Inc Live Share Price Today, Share Analysis and Chart

Name: Cabaletta Bio Inc: Is Infosys Ltd. worth buying?
Item: Cabaletta Bio Inc
Rating: 0.97525
Author: Trendlyne DVM scores

about

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-medi...

1.15 -0.13 (-10.16%)

91.48% Fall from 52W High

650.1K XNAS Volume

XNAS 06 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Cabaletta Bio Inc is on 15 May 2025 for the purpose of Cabaletta Bio Inc First Quarter Earnings Results for 2025 See details

Not Eligible

-

Expensive Valuation

14.5 / 100

Technically Bearish

24.5 / 100

No estimates available

Cabaletta Bio Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cabaletta Bio Inc FAQ

How is Cabaletta Bio Inc today?

Cabaletta Bio Inc today is trading in the red, and is down by -10.16% at 1.15.

How has Cabaletta Bio Inc performed historically?

Cabaletta Bio Inc is currently trading down -10.16% on an intraday basis. In the past week the stock fell -12.21%. stock has been down -52.87% in the past quarter and fell -90.72% in the past year. You can view this in the overview section.